A small divvy is not on the cards because history shows that the directors prefer to save any excess funds to be used to increase their director fees in the near and distant future.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025